These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30055465)

  • 41. DCLAK11, a multi-tyrosine kinase inhibitor, exhibits potent antitumor and antiangiogenic activity in vitro.
    Guo XB; Chen XJ; Tong LJ; Peng X; Huang M; Liu HC; Liu H; Ding J
    Acta Pharmacol Sin; 2015 Oct; 36(10):1266-76. PubMed ID: 26027659
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-tumor angiogenesis effect of a new compound: B-9-3 through interference with VEGFR2 signaling.
    Ma Q; Chen W; Chen W
    Tumour Biol; 2016 May; 37(5):6107-16. PubMed ID: 26611645
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fe3O4 Nanoparticles Mediated Synthesis of Novel Isatin-dihydropyrimidinone Hybrid Molecules as Antioxidant and Cytotoxic Agents.
    Maddela S; Makula A; Jayarambabu N
    Anticancer Agents Med Chem; 2017; 17(3):456-463. PubMed ID: 27173964
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, synthesis and in vitro evaluation of 6-amide-2-aryl benzoxazole/benzimidazole derivatives against tumor cells by inhibiting VEGFR-2 kinase.
    Yuan X; Yang Q; Liu T; Li K; Liu Y; Zhu C; Zhang Z; Li L; Zhang C; Xie M; Lin J; Zhang J; Jin Y
    Eur J Med Chem; 2019 Oct; 179():147-165. PubMed ID: 31252306
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
    Al-Salahi OS; Kit-Lam C; Majid AM; Al-Suede FS; Mohammed Saghir SA; Abdullah WZ; Ahamed MB; Yusoff NM
    Microvasc Res; 2013 Nov; 90():30-9. PubMed ID: 23899415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Macrocyclic Ruthenium(III) Complex Inhibits Angiogenesis with Down-Regulation of Vascular Endothelial Growth Factor Receptor-2 and Suppresses Tumor Growth In Vivo.
    Kwong WL; Lam KY; Lok CN; Lai YT; Lee PY; Che CM
    Angew Chem Int Ed Engl; 2016 Oct; 55(43):13524-13528. PubMed ID: 27717148
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New 2,4-disubstituted-2-thiopyrimidines as VEGFR-2 inhibitors: Design, synthesis, and biological evaluation.
    Abdel-Mohsen HT; Girgis AS; Mahmoud AEE; Ali MM; El Diwani HI
    Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900089. PubMed ID: 31463965
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diosmetin inhibits tumor development and block tumor angiogenesis in skin cancer.
    Choi J; Lee DH; Park SY; Seol JW
    Biomed Pharmacother; 2019 Sep; 117():109091. PubMed ID: 31228803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-angiogenic effects of novel cyclin-dependent kinase inhibitors with a pyrazolo[4,3-d]pyrimidine scaffold.
    Zhang S; Ulrich M; Gromnicka A; Havlíček L; Kryštof V; Jorda R; Strnad M; Vollmar AM; Zahler S
    Br J Pharmacol; 2016 Sep; 173(17):2645-56. PubMed ID: 27390037
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chalcones incorporated pyrazole ring inhibit proliferation, cell cycle progression, angiogenesis and induce apoptosis of MCF7 cell line.
    Mohamed MF; Mohamed MS; Fathi MM; Shouman SA; Abdelhamid IA
    Anticancer Agents Med Chem; 2014; 14(9):1282-92. PubMed ID: 25323033
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and biological evaluation of N-(4-hydroxy-3-mercaptonaphthalen-1-yl)amides as inhibitors of angiogenesis and tumor growth.
    Xu F; Jia Y; Wen Q; Wang X; Zhang L; Zhang Y; Yang K; Xu W
    Eur J Med Chem; 2013 Jun; 64():377-88. PubMed ID: 23644219
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functionalized azirine based scaffolds as endothelin inhibitors for the selective anti-angiogenic activity.
    Singh H; Satish N; Babu TR; Singh A; Yadav B; Singh SK; Wahajuddin M; Siddiqui MI; Jagavelu K; Sudhakar G
    Eur J Med Chem; 2024 Aug; 274():116510. PubMed ID: 38843585
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pyrazolo-benzothiazole hybrids: Synthesis, anticancer properties and evaluation of antiangiogenic activity using in vitro VEGFR-2 kinase and in vivo transgenic zebrafish model.
    Reddy VG; Reddy TS; Jadala C; Reddy MS; Sultana F; Akunuri R; Bhargava SK; Wlodkowic D; Srihari P; Kamal A
    Eur J Med Chem; 2019 Nov; 182():111609. PubMed ID: 31445229
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel chalcone derivatives as hypoxia-inducible factor (HIF)-1 inhibitor: synthesis, anti-invasive and anti-angiogenic properties.
    Wang L; Chen G; Lu X; Wang S; Han S; Li Y; Ping G; Jiang X; Li H; Yang J; Wu C
    Eur J Med Chem; 2015 Jan; 89():88-97. PubMed ID: 25462229
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and antiangiogenic activity of novel gambogic acid derivatives.
    Chen T; Zhang RH; He SC; Xu QY; Ma L; Wang GC; Qiu N; Peng F; Chen JY; Qiu JX; Peng AH; Chen LJ
    Molecules; 2012 May; 17(6):6249-68. PubMed ID: 22634837
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel anthraquinone based chalcone analogues containing an imine fragment: synthesis, cytotoxicity and anti-angiogenic activity.
    Kolundžija B; Marković V; Stanojković T; Joksović L; Matić I; Todorović N; Nikolić M; Joksović MD
    Bioorg Med Chem Lett; 2014 Jan; 24(1):65-71. PubMed ID: 24332490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design, synthesis and QSAR study of certain isatin-pyridine hybrids as potential anti-proliferative agents.
    Eldehna WM; Altoukhy A; Mahrous H; Abdel-Aziz HA
    Eur J Med Chem; 2015 Jan; 90():684-94. PubMed ID: 25499988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and biological evaluation of novel N
    Guo L; Ma Q; Chen W; Fan W; Zhang J; Dai B
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):375-387. PubMed ID: 30734606
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and biological evaluation of phenyl substituted polyoxygenated xanthone derivatives as anti-hepatoma agents.
    Dai M; Yuan X; Kang J; Zhu ZJ; Yue RC; Yuan H; Chen BY; Zhang WD; Liu RH; Sun QY
    Eur J Med Chem; 2013 Nov; 69():159-66. PubMed ID: 24013415
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo.
    Zhang S; Cao Z; Tian H; Shen G; Ma Y; Xie H; Liu Y; Zhao C; Deng S; Yang Y; Zheng R; Li W; Zhang N; Liu S; Wang W; Dai L; Shi S; Cheng L; Pan Y; Feng S; Zhao X; Deng H; Yang S; Wei Y
    Clin Cancer Res; 2011 Jul; 17(13):4439-50. PubMed ID: 21622720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.